Neuroblastoma: validation of the INRG classification system in a small series
In 2009, the International Neuroblastoma Risk Group (INRG) published a new classification system of the childhood neuroblastic tumors. In this work, we present the results of the application of this new classification system in our patients.
We conducted a retrospective analysis of the patients diagnosed with a neuroblastic tumor in our center in the last 20 years. We classified them according to the new classification and performed a survival analysis based on the Kaplan–Meier method and Mantel–Cox test.
The five-year event-free survival (5-year EFS) was 95.8, 80.8, 50 and 45.9% for the very low, low, intermediate and high-risk groups. Mantel–Cox test showed statistically significant differences between these risk groups (p = 0.002).
The 5-year EFS for the different risk groups was similar to the expected by the INRG. Therefore, this classification allows us to predict the evolution of this tumor and apply the correct intensity of treatment.
KeywordsNeuroblastoma Classification Tumor staging Prognosis
We would like to acknowledge the Asociación Pablo Ugarte for its support for pediatric oncology research in Spain.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study, formal consent is not required.
- 8.Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Ceccheto G, Holmes K, et al. The International Neuroblastoma risk Group (INRG) staging system: an INRG Task Force Report.Google Scholar